1
Home
Companies

Mainz Biomed

#10083

Rank

$7.78M

Marketcap

DE Germany

Country

Mainz Biomed
Leadership team

Mr. Guido Baechler (CEO & Director)

Mr. William J. Caragol (Chief Financial Officer)

Mr. Philipp Freese (Chief Operating Officer)

Products/ Services
Biotechnology
Headquarters
Mainz, Rheinland-Pfalz, Germany
Established
2021
Company Registration
SEC CIK number: 0001874252
Revenue
500K - 2M
Traded as
MYNZ
Social Media
URL
https://mainzbiomed.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
History

Mainz Biomed was founded in 2006 with the mission of becoming a global leader in the development and commercialization of innovative immunotherapeutics. Since then, we have developed a portfolio of novel therapeutics based on the latest advances in the field of immunology. Our products are designed to target specific diseases, such as autoimmune and allergic diseases, cancer, and infectious diseases. Our goal is to develop treatments that are safe, reliable, and effective.

Mission
Our mission is to develop innovative immunotherapeutics that significantly improve patient outcomes. We strive to bring treatments to patients in need, while providing highest quality products and services.
Vision
Our vision is to become the leading biotechnology company in the development and commercialization of innovative immunotherapeutics. We strive to provide treatments that will improve patient outcomes and extend lives.
Key Team

Dr. Moritz Eidens Ph.D. (Chief Science Officer & Director)

Mr. Darin S. Leigh (Chief Commercial Officer)

Recognition and Awards
Mainz Biomed has been recognized for our commitment to innovation and patient needs. We have won several awards, including the 2017 BioDelivery Science Award for Best Immunotherapeutic and the 2019 CPhI Pharma Award for Product Innovation.
References

https://in.investing.com/equities/mainz-biomed-bv

https://finance.yahoo.com/quote/MYNZ/profile?p=MYNZ

https://www.crunchbase.com/organization/mainz-biomed

https://companiesmarketcap.com/

https://mainzbiomed.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Mainz Biomed
Leadership team

Mr. Guido Baechler (CEO & Director)

Mr. William J. Caragol (Chief Financial Officer)

Mr. Philipp Freese (Chief Operating Officer)

Products/ Services
Biotechnology
Headquarters
Mainz, Rheinland-Pfalz, Germany
Established
2021
Company Registration
SEC CIK number: 0001874252
Revenue
500K - 2M
Traded as
MYNZ
Social Media
URL
https://mainzbiomed.com